ArticleVaccines2025
Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives.
Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Catching our breath: development of interventions and therapies for respiratory syncytial virus.Microbiology and molecular biology reviews : MMBR · 2026Review
- Incidence of respiratory syncytial virus infections among children in rural Bangladesh: a prospective observational study (2021-2023).The Lancet regional health. Southeast Asia · 2026Article
- Risk factors for ICU admission in hospitalized children with respiratory syncytial virus infection.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND/
objectivesThe CDC has recommended immunizations to protect infants during the respiratory syncytial virus (RSV) season, which varies annually and geographically. Seasonal differences in RSV hospitalizations among infants are not well studied.
methodsThis retrospective cohort study identified infants < 12 months old hospitalized with RSV from the PINC AI Healthcare Database during the 2018-2023 surveillance years (1 July-30 June). Monthly RSV hospitalizations were stratified by U.S. census division and age group (<3, 3-5, 6-8, 9-11 months). Patient characteristics, healthcare resource utilization (HCRU), and cost were compared between typical in-season months (October-March) and typical off-season months (April-September) for RSV hospitalizations.
resultsAmong 20,531 hospitalizations for RSV (mean age: 4.1 months, 56.4% male), 22% (
conclusionsThere is an unmet need among the 1 in 5 infants with off-season RSV hospitalizations, which are associated with higher HCRU and costs. Current recommendations on RSV preventives offer limited protection for infants exposed to RSV outside the typical season.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.